MTOR and Obesity: Data from patients suffering from obesity and T2D showed reduced activity of mammalian target of rapamycin (mTOR), and lower insulin receptor substrate 1 (IRS1) levels in adipocytes from subcutaneous fat with higher autophagy activation compared with nondiabetic patients39.